WO2023219592A3 - A tablet composition comprising paracetamol, chlorpheniramine and ascorbic acid - Google Patents
A tablet composition comprising paracetamol, chlorpheniramine and ascorbic acid Download PDFInfo
- Publication number
- WO2023219592A3 WO2023219592A3 PCT/TR2023/050423 TR2023050423W WO2023219592A3 WO 2023219592 A3 WO2023219592 A3 WO 2023219592A3 TR 2023050423 W TR2023050423 W TR 2023050423W WO 2023219592 A3 WO2023219592 A3 WO 2023219592A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- paracetamol
- ascorbic acid
- chlorpheniramine
- tablet composition
- antipyretic
- Prior art date
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 6
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title abstract 2
- 235000010323 ascorbic acid Nutrition 0.000 title abstract 2
- 239000011668 ascorbic acid Substances 0.000 title abstract 2
- 229960005070 ascorbic acid Drugs 0.000 title abstract 2
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 title 1
- 229960003291 chlorphenamine Drugs 0.000 title 1
- 229960005489 paracetamol Drugs 0.000 title 1
- 239000007916 tablet composition Substances 0.000 title 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000007941 film coated tablet Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002636 symptomatic treatment Methods 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a film-coated tablet composition comprising Paracetamol (Acetaminophen), Chlorpheniramine maleate and Ascorbic Acid (Vitamin C) with analgesic, antipyretic and antihistamine effect for the symptomatic treatment of cold and flu.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2022/007536A TR2022007536A2 (en) | 2022-05-09 | 2022-05-09 | TABLET COMPOSITION CONTAINING PARACETAMOL, CHLORPHENIRAMINE AND ASCORBIC ACID |
| TR2022/007536 | 2022-05-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2023219592A2 WO2023219592A2 (en) | 2023-11-16 |
| WO2023219592A3 true WO2023219592A3 (en) | 2024-03-14 |
Family
ID=84046575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/TR2023/050423 WO2023219592A2 (en) | 2022-05-09 | 2023-05-08 | A tablet composition comprising paracetamol, chlorpheniramine and ascorbic acid |
Country Status (2)
| Country | Link |
|---|---|
| TR (1) | TR2022007536A2 (en) |
| WO (1) | WO2023219592A2 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2187312A1 (en) * | 1972-06-05 | 1974-01-18 | Blum Jean | Rapidly-soluble paracetamol - prepd by recrystallization from aqueous dioxan |
| CN102727625A (en) * | 2011-03-30 | 2012-10-17 | 赵文志 | Improved preparation of compound Ganmaoling tablet |
| CN102908550A (en) * | 2012-11-14 | 2013-02-06 | 广西盈康药业有限责任公司 | Sugar-free vitamin C fructus forsythiae particles and preparation method thereof |
| US11090315B1 (en) * | 2020-03-18 | 2021-08-17 | Mihan Jafari JAVID | Prevention and treatment of flu-type viral infections and related complications |
-
2022
- 2022-05-09 TR TR2022/007536A patent/TR2022007536A2/en unknown
-
2023
- 2023-05-08 WO PCT/TR2023/050423 patent/WO2023219592A2/en unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2187312A1 (en) * | 1972-06-05 | 1974-01-18 | Blum Jean | Rapidly-soluble paracetamol - prepd by recrystallization from aqueous dioxan |
| CN102727625A (en) * | 2011-03-30 | 2012-10-17 | 赵文志 | Improved preparation of compound Ganmaoling tablet |
| CN102908550A (en) * | 2012-11-14 | 2013-02-06 | 广西盈康药业有限责任公司 | Sugar-free vitamin C fructus forsythiae particles and preparation method thereof |
| US11090315B1 (en) * | 2020-03-18 | 2021-08-17 | Mihan Jafari JAVID | Prevention and treatment of flu-type viral infections and related complications |
Also Published As
| Publication number | Publication date |
|---|---|
| TR2022007536A2 (en) | 2022-06-21 |
| WO2023219592A2 (en) | 2023-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20082744L (en) | Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetylsalicylic acid | |
| WO2004055006A8 (en) | Novel compounds having selective inhibiting effect at gsk3 | |
| WO2009006095A3 (en) | Dual portion lozenge dosage form | |
| HUP0401978A2 (en) | Tamsulosin tablets | |
| DK1161248T3 (en) | Pharmaceutical composition containing a source of nitrate and an acidifying agent for the treatment of open wounds and burns | |
| ATE514418T1 (en) | RAPIDLY DISRUPTING SOLID DOSAGE FORMS WITH NON-FRUABLE CONSISTENCY AND PULLULAN | |
| WO2006102446A3 (en) | Multi-particulate, modified-released colonic composition | |
| NO20084065L (en) | Quick-release paracetamol tablets | |
| WO2004030611A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| DK1781277T3 (en) | Combination composition comprising Ibuprofen and Paracetamol | |
| CR7074A (en) | MERCAPTOACETYLAMIDA DERIVATIVES AND PROCESS FOR PREPARATION AND USE | |
| WO2008017867A3 (en) | Antiretroviral solid oral composition with at least one water insoluble polymer | |
| WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
| WO2005035485A3 (en) | Analgesic compounds, their synthesis and pharmaceutical compositions containing them | |
| PH12020551555A1 (en) | Calpain modulators and therapeutic uses thereof | |
| WO2003051398A8 (en) | Parenteral composition of paracetamol | |
| MX2012001853A (en) | Pharmaceutical composition for suppressing pain. | |
| SI1404304T1 (en) | Tablet comprising cetirizine and pseudoephedrine | |
| WO2023219592A3 (en) | A tablet composition comprising paracetamol, chlorpheniramine and ascorbic acid | |
| ZA200506992B (en) | Fibrate tablet and method for the production thereof | |
| BG108452A (en) | Tablet comprising cetirizine and pseudoephedrine | |
| Ganjehei et al. | Aspirin dosing in cardiovascular disease prevention and management: an update | |
| Daniels et al. | Clinical efficacy and safety of tapentadol immediate release in the postoperative setting | |
| US4260600A (en) | Method of treating depression | |
| MXPA02010828A (en) | Pharmaceutical composition in capsules comprising a non-steroidal anti-inflammatory and an opiate analgesic for handling pain. |